Activesite Pharmaceuticals
ActiveSite Pharmaceuticals, based in Berkeley, CA, specializes in proprietary lead discovery technology aimed at identifying new small molecule drug candidates to address human diseases with significant unmet medical needs. The company's primary focus is on developing innovative treatments for diabetic macular edema and hereditary angioedema by targeting the vascular protease plasma kallikrein.
With its commitment to advancing healthcare solutions, ActiveSite Pharmaceuticals is at the forefront of research to tackle vision-threatening complications associated with diabetes and genetic disorders. Their pioneering approach to drug discovery underscores their dedication to improving patient outcomes through novel therapeutic options.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.